维普中文期刊产品整合服务
27篇 您的检索式:作者名="Yonca"
    题名 作者 年代 出处 被引量
1Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model显示文摘AIM: To compare the efficacies of subconjunctival bevacizumab, ranibizumab, and pegaptanib sodium injections for the inhibition of corneal neovascularization in an experimental rat model. METHODS: Sixteen corneas of 16 rats were chemically cauterized and randomized into four groups: bevacizumab group that treated with 0.05mL/1.25mg bevacizumab, ranibizumab group that treated with 0.05mL/0.5mg ranibizumab, pegaptanib group that treated with 0.05mL/0.15mg pegaptanib sodium, and control group that treated with 0.05mL saline solution. Digital photographs of the corneas were taken and analyzed using an image analysis software program. All corneas were excised and examined histologically on the 15 th day. RESULTS: Each treatment group had significantly less neovascularized corneal areas and fewer blood vessels than the control group (all P <0.05). In addition, bevacizumab group had significantly less neovascu-larized corneal areas and fewer blood vessels than ranibizumab and pegaptanib groups (both P <0.05). However, there was no significant difference between the ranibizumab and pegaptanib groups regarding percentage of neovascularized corneal areas and number of blood vessels (both P >0.05). CONCLUSION: Subconjunctival bevacizumab, ranibiz-umab, and pegaptanib sodium were effective with no corneal epitheliopathy for inhibiting corneal neovascularization after corneal burn in rats .Bevacizumab was more effective than ranibizumab and pegaptanib sodium.Ebru Eren Akar Veysi ner Cem Küükerdnmez Yonca Aydin Akova 2013International Journal of Ophthalmology(English edition)2013,6,2:9
2Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?显示文摘AIM:To assess the effect of topical bevacizumab use on postoperative pterygium recurrence in eyes who underwent pterygium excision with limbal-conjunctival autograft transplantation(LCAT).METHODS:eighty-eight eyes of 88 patients with primary pterygium were included.Pterygia were graded preoperatively from type 1 to type 3(type 1 atrophic,type3 inflamed)according to the inflammatory status.The eyes were preoperatively randomized to receive topical steroid and antibiotic treatment(group 1,46 eyes)and additional topical bevacizumab(5 mg/mL;group 2,42eyes)in the postoperative period.All eyes underwent pterygium excision and LCAT.Medications were tapered and discontinued at one month.Postoperative complications and recurrence rates were recorded.RESULTS:The mean follow-up duration was 29.3±4.2mo(24-52mo)and 28.5±3.4(24-48mo)in group 1 and2,respectively(P>0.05).There were no statistically significant differences regarding the age or gender between groups(P>0.05).Also,the difference between groups with respect to pterygium type was not significant.During the follow-up period,recurrence developed in 2 eyes(4.3%)in group 1,whereas in one eye(2.4%)in group 2.No statistically significant difference between groups was found in recurrence rates(P>0.05).No re-operation for recurrence was necessary during the follow-up period in both groups.CONCLUSION:Topical bevacizumab seems to have no additonal effect on pterygium recurrence after LCAT.Aylin Karalezli Cem Kucukerdonmez Yonca A. Akova Bengu Ekinci Koktekir 2014International Journal of Ophthalmology(English edition)2014,7,3:3
3Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis显示文摘Dear Sir,Iam Yonca A.Akova,MD-from the Department of Ophthalmology,Bayindir Kavaklidere Hospital,Turkey.I wrote this letter to evaluate the efficacy of 0.05%topical cyclosporine A(CsA)eye drops(Restasis Allergan,Irvine,USA)in symptomatic patients with recurrent subepithelial infiltrates(SEIs)due to adenoviral keratoconjunctivitis following steroid eye drops tapering or discontinuation.Ilkay Kilic Muftuoglu Yonca A.Akova Sirel G.Gungor 2016International Journal of Ophthalmology(English edition)2016,9,4:2
4Comparison of Conjunctival Autograft With Amniotic Membrane Transplantation for Pterygium Surgery: Surgical and Cosmetic Outcome显示文摘Cem Kü?ükerd?nmez Yonca A Akova Dilek Dursun Altn?rs 2007Cornea2007,,4:1
5Aroma active and off flavor compounds of nonfat dried milk显示文摘YONCA K Y 2002J Agrie Food Chem2002,50,2:1
6Aroma ctive and off flavor compounds of nonfat dried milk显示文摘Karagul Yuceer Yonca 0,,:1
7Transofrmation of a SimPle Plastic into a SuPerhydro Phobie Surafee显示文摘H Yildirim A Levent Demirel Yonca A Veietc 2003Seienee Journal2003,299,8:1
8Severe Corneal Changes following Intravitreal Injection of Bevacizumab显示文摘Sezin Akca Bayar Dilek D. Altinors Cem Kucukerdonmez Yonca A. Akova 2010Ocular Immunology and Inflammation2010,,4:1
9Effect of one -step polishing systems on surface roughness of different flowable restorative materials 显示文摘Emre OZEL Yonca KORKMAZ Nuray ATTAR 2008J Dental Materials2008,27,6:1
10The Way Forward with Historic Urban Landscape Approach Towards Sustainable Urban Development显示文摘The pace of urbanisation,with the increase in the number of metropolitan areas,has been paralleled with the heritage discourse of past generations that valorises monuments in isolation,and has pushed the ap­preciation of urban heritage to a grim corner in the face of development.Since the turn of the millennium there are international efforts to reverse this trend by placing culture and people-centred approaches into the heritage discourse in order to allow inclusive policies that see culture and cultural heritage as an asset and driving force for sustainable urban development.As one of such instruments,the UNESCO Recommendation on the Historic Urban Landscape,as an integrated management model,is considered in this article to have potentials to bridge existing divides to achieve sustainable urban development.With this belief,the paper looks into the future,with supporting arguments that come from discussions as a result of the WHITRAP International Expert Meeting on the Implemen­tation of the HUL approach which took place in 2018,Shanghai,China.Yonca Erkan 2018Built Heritage2018,2,4:1
11Aroma-active and off-flavor compounds of nonfat dried milk显示文摘 Yonca 2002Food science and teconology2002,33,:1
12Nasolacrimal Duct Obstruction: Clinicopathologic Analysis of 205 Cases显示文摘Rana Altan-Yaycioglu Handan Canan Selcuk Sizmaz Nebil Bal Aysel Pelit Yonca A. Akova 2010Orbit2010,,5:1
13MRspectroscopy findings in tuberculousspondylitis;comparison with modictype-iend-plate changes and metastatic vertebral disease显示文摘Yonca Ank Ercument Ciftci Hasan Tahsin Sarisoy 2008European Journal of Radiology2008,3885,:1
14Measure for measure:the relation between forecast accuracy and recommendation profitability显示文摘Yonca Ertimur Jayanthi Sunder Shyam V Sunder 2007Journal of Accounting Research2007,45,3:1
15Primary Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Occurring in the Rectum: A Case Report and Review of the Literature显示文摘Sushil Ahlawat Yonca Kanber Aline Charabaty-Pishvaian Metin Ozdemirli Philip Cohen Stanley Benjamin Nadim Haddad 2006Southern Medical Journal2006,,12:1
16Driven Equilibrium(Drive) MR Imaging of the Cranial Nerves V~Ⅷ:Comparison with the T2-weighted 3D TSE Sequence显示文摘Ciftci E Yonca Anik Arzu Arslan 2004J Clin Neurosci2004,11,5:1
17Pedicle morphology of the thoracic spine in preadolescent idiopathic scoliosis:magnetic resonance supported analysis显示文摘Hu Seyin Levent Buluc Yonca An 2007Eur Spine2007,16,:1
18Subconjunctival bevacizumab in the impending recurrent pterygia显示文摘Sezin Akca Bayar Cem Kucukerdonmez Ozlem Oner Yonca A. Akova 2014International Ophthalmology2014,,3:1
19Aroma ctive and off flavor compounds of nonfat dried milk 显示文摘Karagul Yuceer Yonca 2002Food science and teconology2002,33,:1
20Influence of different conditioning methods on the shear bond strength of novel lightcuring nano-ionomer restorative to enamel and dentin显示文摘Yonca K Ceren O Emre O 2010Lasers Meal Sci2010,25,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费